Where is the live CopyMark page for USPTO serial 85780732?

The live record is at https://getcopymark.com/trademark/85780732. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns INTELLIVENGE?

According to the public USPTO record for serial number 85780732, the listed owner(s) include: Dendreon Corporation, DENDREON PHARMACEUTICALS, INC., Dendreon Corporation.

What is USPTO serial number 85780732?

Serial number 85780732 is the USPTO application identifier for the mark INTELLIVENGE. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover INTELLIVENGE?

The public record lists International Classes: 009, 042, 044. Each class corresponds to categories of goods or services identified in the application or registration.

4.9/5

USPTO serial 85780732

INTELLIVENGE

Q: What is the current status of INTELLIVENGE?

INTELLIVENGE (85780732) currently shows USPTO status code 606 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Reviewed by CopyMark Law Group

Status 606

Filing date: Nov 15, 2012
Status date: Jul 13, 2015
Registration date: —
Examiner: TRIPI, CYNTHIA
Law office: INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INTELLIVENGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Dendreon Corporation
Seattle, WA
Other trademarks owned by Dendreon Corporation
DENDREON PHARMACEUTICALS, INC.
BRIDGEWATER, NJ
Other trademarks owned by DENDREON PHARMACEUTICALS, INC.
Dendreon Corporation
Seattle, WA
Other trademarks owned by Dendreon Corporation

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Denis A. Polyn

Denis A. Polyn Valeant Pharmaceuticals International, Inc.1400 N. Goodman StreetRochester, NY 14609UNITED STATES

Goods and services

Class	Description	Status	First use
009	Computer software used for scheduling, controlling, tracking, monitoring, managing, analyzing and recording medical and laboratory procedures for patients; computer software used for scheduling, controlling, tracking, monitoring, managing, and recording shipment and transmission of patient medical information, laboratory samples, diagnostic samples and clinical samples; computer software for controlling, scheduling, tracking, monitoring, managing, analyzing, recording, and ensuring the transmission security and integrity of medical and diagnostic data and information	ACTIVE	—
042	Consulting services in the fields of biotechnology, pharmaceutical research and development, and laboratory medical sample testing for scientific and research purposes; research and development in the fields of medical, pharmaceutical, diagnostic and blood treatment products and procedures; computer services, namely, providing a website featuring online non-downloadable software that enables users to remotely manage, administer, modify and control their end user computer devices and software applications to implement, schedule, control, track, monitor, manage, process, analyze and record medical and laboratory procedures for patients and shipment and transmission of patient medical information, laboratory samples, diagnostic medical samples and clinical medical samples; medical laboratory services	ACTIVE	—
044	Medical diagnostic testing, monitoring and reporting services; medical treatment services; blood testing, and blood treatment and processing for the purpose of medical clinical diagnosis; consulting services in the fields of medical treatment and medicines, medical diagnostic testing, and diagnostic and clinical blood treatment procedure	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jul 29, 2015	ASCK	ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY	—
Jul 15, 2015	ASGN	AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	—
Jul 13, 2015	MAB6	ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 13, 2015	ABN6	ABANDONMENT - NO USE STATEMENT FILED	The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 20, 2015	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 20, 2015	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Dec 18, 2014	EXRA	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	—
Dec 17, 2014	EX2G	SOU EXTENSION 2 GRANTED	—
Dec 10, 2014	EXT2	SOU EXTENSION 2 FILED	—
Dec 10, 2014	EEXT	SOU TEAS EXTENSION RECEIVED	The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2014	EXRA	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	—
Jun 12, 2014	EX1G	SOU EXTENSION 1 GRANTED	—
Jun 10, 2014	AITU	CASE ASSIGNED TO INTENT TO USE PARALEGAL	—
May 23, 2014	EXT1	SOU EXTENSION 1 FILED	—
May 23, 2014	EEXT	SOU TEAS EXTENSION RECEIVED	The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 10, 2013	NOAM	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 6, 2013	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Oct 15, 2013	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Oct 15, 2013	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2013	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Sep 12, 2013	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Sep 12, 2013	ALIE	ASSIGNED TO LIE	—
Sep 3, 2013	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Aug 31, 2013	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Aug 30, 2013	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Aug 30, 2013	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 12, 2013	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2013	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2013	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2013	DOCK	ASSIGNED TO EXAMINER	—
Nov 27, 2012	MPMK	NOTICE OF PSEUDO MARK MAILED	—
Nov 26, 2012	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Nov 19, 2012	NWAP	NEW APPLICATION ENTERED	—